Artesunate versus chloroquine infection-treatment-vaccination defines stage-specific immune responses associated with prolonged sterile protection against both pre-erythrocytic and erythrocytic plasmodium yoelii infection

Journal of Immunology

Volumn 193, Issue 3, 2014, Pages 1268-1277

  Peng, Xiaohong ^a,b   Keitany, Gladys J ^b   Vignali, Marissa ^b   Chen, Lin ^a,b   Gibson, Claire ^b   Choi, Kimberly ^b   Huang, Fusheng ^a   Wang, Ruobing ^b,c  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; CHLOROQUINE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PARASITE; CD8+ T LYMPHOCYTE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; EFFECTOR CELL; ERYTHROCYTE; FEMALE; IMMUNE RESPONSE; IN VITRO STUDY; INFECTION PREVENTION; LIVER CELL; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM YOELII INFECTION; PRIORITY JOURNAL; TROPHOZOITE;

ANIMALS; ANOPHELES; ANTIBODIES, PROTOZOAN; ANTIMALARIALS; ARTEMISIA; ARTEMISININS; CHLOROQUINE; ERYTHROCYTES; FEMALE; MALARIA; MALARIA VACCINES; MICE; MICE, INBRED BALB C; PHYTOTHERAPY; PLASMODIUM YOELII; SPOROZOITES; TIME FACTORS; VACCINES, ATTENUATED;

EID: 84906090292     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400296     Document Type: Article

References (45)

1. World Health Organization. 2013. World Malaria Report 2013. Geneva, Switzerland: WHO. Available at: http://www.who.int/malaria/publications/world- malaria-report-2013/en/. Accessed January 22, 2014.
2. Wang, R., J. D. Smith, and S. H. Kappe. 2009. Advances and challenges in malaria vaccine development. Expert Rev. Mol. Med. 11: e39.
3. Vaughan, A. M., R. Wang, and S. H. Kappe. 2010. Genetically engineered, attenuated whole-cell vaccine approaches for malaria. Hum. Vaccin. 6: 107-113.
4. Clyde, D. F., V. C. McCarthy, R. M. Miller, and R. B. Hornick. 1973. Specificity of protection of man immunized against sporozoite-induced falciparum malaria. Am. J. Med. Sci. 266: 398-403.
5. Hoffman, S. L., L. M. Goh, T. C. Luke, I. Schneider, T. P. Le, D. L. Doolan, J. Sacci, P. de la Vega, M. Dowler, C. Paul, et al. 2002. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J. Infect. Dis. 185: 1155-1164.
6. Rieckmann, K. H., R. L. Beaudoin, J. S. Cassells, and K. W. Sell. 1979. Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria. Bull. World Health Organ. 57(Suppl. 1): 261-265.
7. Seder, R. A., L. J. Chang, M. E. Enama, K. L. Zephir, U. N. Sarwar, I. J. Gordon, L. A. Holman, E. R. James, P. F. Billingsley, A. Gunasekera, et al; VRC 312 Study Team. 2013. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science 341: 1359-1365.
8. Belnoue, E., F. T. Costa, T. Frankenberg, A. M. Vigário, T. Voza, N. Leroy, M. M. Rodrigues, I. Landau, G. Snounou, and L. Rénia. 2004. Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J. Immunol. 172: 2487-2495.
9. Friesen, J., O. Silvie, E. D. Putrianti, J. C. Hafalla, K. Matuschewski, and S. Borrmann. 2010. Natural immunization against malaria: causal prophylaxis with antibiotics. Sci. Transl. Med. 2: 40ra49.
10. Putrianti, E. D., O. Silvie, M. Kordes, S. Borrmann, and K. Matuschewski. 2009. Vaccine-like immunity against malaria by repeated causal-prophylactic treatment of liver-stage Plasmodium parasites. J. Infect. Dis. 199: 899-903.
11. Roestenberg, M., M. McCall, J. Hopman, J. Wiersma, A. J. Luty, G. J. van Gemert, M. van de Vegte-Bolmer, B. van Schaijk, K. Teelen, T. Arens, et al. 2009. Protection against a malaria challenge by sporozoite inoculation. N. Engl. J. Med. 361: 468-477.
12. Roestenberg, M., E. M. Bijker, B. K. Sim, P. F. Billingsley, E. R. James, G. J. Bastiaens, A. C. Teirlinck, A. Scholzen, K. Teelen, T. Arens, et al. 2013. Controlled human malaria infections by intradermal injection of cryopreserved Plasmodium falciparum sporozoites. Am. J. Trop. Med. Hyg. 88: 5-13.
13. Bray, P. G., S. A. Ward, and P. M. O'Neill. 2005. Quinolines and artemisinin: chemistry, biology and history. Curr. Top. Microbiol. Immunol. 295: 3-38.
14. Klonis, N., S. C. Xie, J. M. McCaw, M. P. Crespo-Ortiz, S. G. Zaloumis, J. A. Simpson, and L. Tilley. 2013. Altered temporal response of malaria parasites determines differential sensitivity to artemisinin. Proc. Natl. Acad. Sci. USA 110: 5157-5162.
15. White, N. J. 2008. Qinghaosu (artemisinin): the price of success. Science 320: 330-334.
16. Nganou-Makamdop, K., G. J. van Gemert, T. Arens, C. C. Hermsen, and R. W. Sauerwein. 2012. Long term protection after immunization with P. berghei sporozoites correlates with sustained IFNg responses of hepatic CD8+ memory T cells. PLoS ONE 7: e36508.
17. Bijker, E. M., G. J. Bastiaens, A. C. Teirlinck, G. J. van Gemert, W. Graumans, M. van de Vegte-Bolmer, R. Siebelink-Stoter, T. Arens, K. Teelen, W. Nahrendorf, et al. 2013. Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity. Proc. Natl. Acad. Sci. USA 110: 7862-7867.
18. Trimnell, A., A. Takagi, M. Gupta, T. L. Richie, S. H. Kappe, and R. Wang. 2009. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes. J. Immunol. 183: 5870-5878.
19. Doll, K. L., N. S. Butler, and J. T. Harty. 2014. CD8 T cell independent immunity after single dose infection-treatment-vaccination (ITV) against Plasmodium yoelii. Vaccine 32: 483-491.
20. Butler, N. S., N. W. Schmidt, A. M. Vaughan, A. S. Aly, S. H. Kappe, and J. T. Harty. 2011. Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites. Cell Host Microbe 9: 451-462.
21. Rénia, L. 2008. Protective immunity against malaria liver stage after vaccination with live parasites. Parasite 15: 379-383.
22. Nganou-Makamdop, K., and R. W. Sauerwein. 2013. Liver or blood-stage arrest during malaria sporozoite immunization: the later the better? Trends Parasitol. 29: 304-310.
23. Belnoue, E., T. Voza, F. T. Costa, A. C. Grüner, M. Mauduit, D. S. Rosa, N. Depinay, M. Kayibanda, A. M. Vigário, D. Mazier, et al. 2008. Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage. J. Immunol. 181: 8552-8558.
24. Miller, J. L., S. Murray, A. M. Vaughan, A. Harupa, B. Sack, M. Baldwin, I. N. Crispe, and S. H. Kappe. 2013. Quantitative bioluminescent imaging of preerythrocytic malaria parasite infection using luciferase-expressing Plasmodium yoelii. PLoS ONE 8: e60820.
25. Dong, Z. J., H. M. Wei, R. Sun, Z. G. Tian, and B. Gao. 2004. Isolation of murine hepatic lymphocytes using mechanical dissection for phenotypic and functional analysis of NK1.1+ cells. World J. Gastroenterol. 10: 1928-1933.
26. Sack, B. K., J. L. Miller, A. M. Vaughan, A. Douglass, A. Kaushansky, S. Mikolajczak, A. Coppi, G. Gonzalez-Aseguinolaza, M. Tsuji, F. Zavala, et al. 2014. Model for in vivo assessment of humoral protection against malaria sporozoite challenge by passive transfer of monoclonal antibodies and immune serum. Infect. Immun. 82: 808-817.
27. Murphy, S. C., A. Kas, B. C. Stone, and M. J. Bevan. 2013. AT-cell response to a liver-stage Plasmodium antigen is not boosted by repeated sporozoite immunizations. Proc. Natl. Acad. Sci. USA 110: 6055-6060.
28. Reyes-Sandoval, A., D. H. Wyllie, K. Bauza, A. Milicic, E. K. Forbes, C. S. Rollier, and A. V. Hill. 2011. CD8+ T effector memory cells protect against liver-stage malaria. J. Immunol. 187: 1347-1357.
29. Cooney, L. A., M. Gupta, S. Thomas, S. Mikolajczak, K. Y. Choi, C. Gibson, I. K. Jang, S. Danziger, J. Aitchison, M. J. Gardner, et al. 2013. Short-lived effector CD8 T cells induced by genetically attenuated malaria parasite vaccination express CD11c. Infect. Immun. 81: 4171-4181.
30. Cockburn, I. A., R. Amino, R. K. Kelemen, S. C. Kuo, S. W. Tse, A. Radtke, L. Mac-Daniel, V. V. Ganusov, F. Zavala, and R. Ménard. 2013. In vivo imaging of CD8+ T cell-mediated elimination of malaria liver stages. Proc. Natl. Acad. Sci. USA 110: 9090-9095.
31. Cockburn, I. A., S. W. Tse, and F. Zavala. 2014. CD8+ T cells eliminate liverstage Plasmodium berghei parasites without detectable bystander effect. Infect. Immun. 82: 1460-1464.
32. Butler, N. S., A. M. Vaughan, J. T. Harty, and S. H. Kappe. 2012. Whole parasite vaccination approaches for prevention of malaria infection. Trends Immunol. 33: 247-254.
33. World Health Organization. 2001. Antimalarial drug combination therapy: report of a WHO technical consultation. Available at: http://whqlibdoc.who.int/ hq/2001/WHO-CDS-RBM-2001.35.pdf. Accessed: January 22, 2014.
34. Dondorp, A. M., F. Nosten, P. Yi, D. Das, A. P. Phyo, J. Tarning, K. M. Lwin, F. Ariey, W. Hanpithakpong, S. J. Lee, et al. 2009. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 361: 455-467.
35. Na-Bangchang, K., and J. Karbwang. 2013. Emerging artemisinin resistance in the border areas of Thailand. Expert. Rev. Clin. Pharmacol. 6: 307-322.
36. Roestenberg, M., A. C. Teirlinck, M. B. McCall, K. Teelen, K. N. Makamdop, J. Wiersma, T. Arens, P. Beckers, G. van Gemert, M. van de Vegte-Bolmer, et al. 2011. Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Lancet 377: 1770-1776.
37. Rénia, L., A. C. Grüner, M. Mauduit, and G. Snounou. 2013. Vaccination using normal live sporozoites under drug treatment. Methods Mol. Biol. 923: 567-576.
38. Schmidt, N. W., N. S. Butler, V. P. Badovinac, and J. T. Harty. 2010. Extreme CD8 T cell requirements for anti-malarial liver-stage immunity following immunization with radiation attenuated sporozoites. PLoS Pathog. 6: e1000998.
39. Doolan, D. L., and S. L. Hoffman. 2000. The complexity of protective immunity against liver-stage malaria. J. Immunol. 165: 1453-1462.
40. Berenzon, D., R. J. Schwenk, L. Letellier, M. Guebre-Xabier, J. Williams, and U. Krzych. 2003. Protracted protection to Plasmodium berghei malaria is linked to functionally and phenotypically heterogeneous liver memory CD8+ T cells. J. Immunol. 171: 2024-2034.
41. Beeson, J. G., F. H. Osier, and C. R. Engwerda. 2008. Recent insights into humoral and cellular immune responses against malaria. Trends Parasitol. 24: 578-584.
42. Good, M. F., D. Stanisic, H. Xu, S. Elliott, and M. Wykes. 2004. The immunological challenge to developing a vaccine to the blood stages of malaria parasites. Immunol. Rev. 201: 254-267.
43. Vaughan, A. M., S. A. Mikolajczak, E. M. Wilson, M. Grompe, A. Kaushansky, N. Camargo, J. Bial, A. Ploss, and S. H. Kappe. 2012. Complete Plasmodium falciparum liver-stage development in liver-chimeric mice. J. Clin. Invest. 122: 3618-3628.
44. Imai, T., J. Shen, B. Chou, X. Duan, L. Tu, K. Tetsutani, C. Moriya, H. Ishida, S. Hamano, C. Shimokawa, et al. 2010. Involvement of CD8+ T cells in protective immunity against murine blood-stage infection with Plasmodium yoelii 17XL strain. Eur. J. Immunol. 40: 1053-1061.
45. Lau, L. S., D. Fernandez Ruiz, G. M. Davey, T. F. de Koning-Ward, A. T. Papenfuss, F. R. Carbone, A. G. Brooks, B. S. Crabb, and W. R. Heath. 2011. Blood-stage Plasmodium berghei infection generates a potent, specific CD8+ T-cell response despite residence largely in cells lacking MHC I processing machinery. J. Infect. Dis. 204: 1989-1996.